Cite
Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study.
MLA
Schwartz JRL, et al. “Modafinil as Adjunct Therapy for Daytime Sleepiness in Obstructive Sleep Apnea: A 12-Week, Open-Label Study.” CHEST, vol. 124, no. 6, Dec. 2003, pp. 2192–99. EBSCOhost, https://doi.org/10.1378/chest.124.6.2192.
APA
Schwartz JRL, Hirshkowitz M, Erman MK, Schmidt-Nowara W, United States Modafinil in OSA Study Group, Schwartz, J. R. L., Hirshkowitz, M., Erman, M. K., & Schmidt-Nowara, W. (2003). Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. CHEST, 124(6), 2192–2199. https://doi.org/10.1378/chest.124.6.2192
Chicago
Schwartz JRL, Hirshkowitz M, Erman MK, Schmidt-Nowara W, United States Modafinil in OSA Study Group, Jonathan R L Schwartz, Max Hirshkowitz, Milton K Erman, and Wolfgang Schmidt-Nowara. 2003. “Modafinil as Adjunct Therapy for Daytime Sleepiness in Obstructive Sleep Apnea: A 12-Week, Open-Label Study.” CHEST 124 (6): 2192–99. doi:10.1378/chest.124.6.2192.